By Editor , 22 September 2026
BCG: Women's Longevity Care Gap Worth $350 Billion Globally

Boston – September 22, 2026 -- Women in perimenopause or menopause represent an estimated $350 billion in unmet demand within the global longevity market, according to a new Boston Consulting Group (BCG) study covering roughly 1 billion women worldwide already spending on longevity products and services.

By Editor , 22 September 2026
China's AI Weather System 'MAZU' Expands to 40+ Countries

Beijing – September 22, 2026 -- China's AI-powered meteorological early-warning system "MAZU" has been deployed for cloud-based trials in more than 40 countries, including Pakistan, Ethiopia, the Solomon Islands, Jordan, Sri Lanka, Mongolia and Djibouti, since its 2025 launch.

By Editor , 22 September 2026
Dangote Urges Africa to Keep Capital Home at Unstoppable Africa 2026

New York – – September 22, 2026 -- Aliko Dangote, President and CEO of Dangote Group, told more than 3,000 African and global business leaders and heads of state that Africa must stop exporting its capital to foreign banks and markets if it wants to replicate Asia's industrial rise. His remarks came at Unstoppable Africa 2026, a two-day forum in New York organized around the theme of continental industrialization and investment.

By Editor , 22 September 2026
Survey: 81% of Security Pros Face Rising Video Storage Costs

Hangzhou, China – September 21, 2026 -- A joint survey by asmag.com and Hikvision found that 38.2% of video security professionals call storage cost or capacity a "major challenge," while another 43.2% rate it "moderate," together accounting for 81.4% of respondents.

By Editor , 22 September 2026

Hong Kong – September 21, 2026 -- Noah Holdings Limited (NYSE: NOAH; HKEX: 6686) hosted its 2026 Global Investor Summit in Hong Kong, gathering investment professionals from Global Infrastructure Partners (a part of BlackRock), Macquarie Asset Management, Bridgepoint, HarbourVest Partners and Sumitomo Mitsui Trust Asset Management to discuss AI-driven shifts in global asset allocation for Chinese high-net-worth families.

By Editor , 22 September 2026
Zenoti CEO Publishes Growth Playbook From 42 Beauty, Wellness Leaders

Seattle – September 21, 2026 -- Sudheer Koneru, CEO and founder of Zenoti, unveiled a new book, Growth Diaries: How the Best Beauty and Wellness Brands Scale from 1 Store to 100+, drawing on interviews with 42 founders, CEOs, and industry leaders across nine countries.

By Editor , 22 September 2026
Merry Life Advances TML-6 Into 210-Patient Global Alzheimer's Phase 2

Taipei – September 21, 2026 -- Merry Life Biomedical has advanced TML-6, a Taiwan-developed oral therapy for early Alzheimer's disease, into a global Phase 2 trial spanning 20 clinical sites across Taiwan, Sweden, and the United States, targeting approximately 210 participants.

By Editor , 22 September 2026
GE Aerospace Board Declares $0.47 Per Share Quarterly Dividend

Cincinnati – September 21, 2026 -- GE Aerospace's Board of Directors declared a $0.47 per share dividend on the company's outstanding common stock, the aerospace propulsion and services group announced.

Dividend payment set for October 26, 2026

The dividend is payable on October 26, 2026, to shareholders of record as of the close of business on October 5, 2026. The ex-dividend date is also set for October 5, 2026, meaning investors purchasing shares on or after that date will not qualify for this payout.

By Editor , 22 September 2026
Pharma Logistics Market to Nearly Double to $194B by 2034

Pune, India – September 21, 2026 -- The global pharmaceutical logistics market is set to nearly double from approximately $100.0 billion in 2025 to $194.0 billion by 2034, expanding at a 7.7% compound annual growth rate, according to a new report from Maximize Market Research.

By Editor , 22 September 2026

Warren, N.J. – September 21, 2026 -- PTC Therapeutics, Inc. (NASDAQ: PTCT) has completed its acquisition of ST-920, a BLA-stage, one-time AAV gene therapy for Fabry disease, from Sangamo Therapeutics, Inc.

PTC targets Q4 2026 completion of rolling BLA submission for accelerated approval

The company confirmed that a rolling Biologics License Application submission to the FDA seeking accelerated approval of ST-920, also known as isaralgagene civaparvovec, is expected to be completed in the fourth quarter of 2026.